New York, NY, Sept. 14, 2018 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Oral Proteins and Peptides Market by Drug Type (Linaclotide, Plecanatide, Calcitonin, Insulin, and Octreotide) and by Application (Gastric & Digestive Disorders, Bone Diseases, Diabetes, Hormonal Disorders, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 – 2024”. According to the report, global oral proteins and peptides market was valued at approximately USD 772.4 million in 2017 and is expected to reach around USD 1671.8 million by 2024, growing at a CAGR of 12.3 % between 2018 and 2024.

The peptide and protein therapeutics are an important class of medicines, which are administered through the oral route to treat different diseases, which include hormonal, gastric, and metabolic disorders. These oral peptide and protein drugs hold a significant potential to improve the human health and are finding applications in the treatment of several diseases. The global oral peptide and protein market is driven by many key developments in the biopharmaceutical industry. First the presence of advanced analytical methods which are promoting rapid drug development and drug discovery. Advancement in the genetic engineering has enabled the large-scale commercial production of polypeptides previously available only in small quantities.

Browse through 29 Tables & 12 Figures spread over 110 Pages and in-depth TOC on “Global Oral Proteins and Peptides Market: By Type, Size, Share, Industry Trends and Forecast, 2018 – 2024”.

Request Free Sample Report of Global Oral Proteins and Peptides Market Report @ https://www.zionmarketresearch.com/sample/oral-proteins-and-peptides-market

The primary factors responsible for the growth of oral proteins and peptides market are increasing the prevalence of chronic diseases, growing awareness regarding the benefits of oral peptides for the treatment of chronic diseases, and improving healthcare infrastructure in emerging economies. Oral peptide and proteins are used in many chronic diseases. Diabetes is one of the chronic diseases which is frequently treated by oral peptides and is expected to boost the growth of the global oral proteins and peptides market in the forecast period. As per the World Health Organization (WHO) estimates, the global prevalence of diabetes among adults has exponentially grown from 4.7% in 1980 to 8.5% in 2014. However, high capital requirements for drug development & drug discovery, contradictions regarding the efficacy and efficiency of oral peptides are restraining the growth of global oral proteins and peptides market. On the other hand, an untapped market, drugs under pipeline and clinical trials are expected to offer profitable opportunities for the key players in the forecast period.

By drug type, the global oral proteins and peptides market is divided into insulin, linaclotide, calcitonin, plecanatide, and octreotide. The insulin segment dominated the market and accounted for the largest share in 2017. Linaclotide was the fastest growing segment and is expected to grab a large share of total revenue in the coming years.

By application segment, the global oral proteins and peptides market is divided into diabetes, bone diseases, hormonal disorders, gastric & digestive disorders, and others. Diabetes was the leading application segment accounting the largest revenue share in 2017. The outsized share of diabetes segment is primarily accredited to the high acceptance of oral insulin in diabetic population and relative increase in the prevalence of diabetes. The bone disease segment is expected to grow at the highest CAGR during the forecast period.

Download Free Report Brochure: https://www.zionmarketresearch.com/requestbrochure/oral-proteins-and-peptides-market

North America was the leading region in oral proteins and peptides market with more than 40% share of the total market in 2017. The U.S. was the leading country in the North America region with the highest growth rate due to the presence of advanced medical facilities and improved healthcare infrastructure. Factors such as enhanced health awareness about benefits of oral peptide drugs among the population, growing inclination toward high-quality treatment, the high prevalence of chronic diseases, and faster penetration of novel drugs and therapies in the market are driving the growth of oral proteins and peptides market. According to the CDC statistics, nearly 30.5 million people have diabetes which contributes almost 9.4% of the US population. The frequency of diabetic patients is expected to expand in the forecast period owing to the presence of 84.1 million adults having pre-diabetes. Pre-diabetes is the forewarning of diabetes which contributes nearly 33.9% of the U.S. adult population.

The Europe oral proteins and peptides market is growing at a very healthy rate and it will be one of the key markets for oral proteins and peptides market globally, representing roughly 30% of global revenue in 2017. The presence of a large number of market players and the growing awareness among consumers about benefits of oral proteins and peptides are some of the imperative aspects expected to fuel the growth of European oral peptide and protein market.

Request a Discount on This Report: https://www.zionmarketresearch.com/requestdiscount/oral-proteins-and-peptides-market

The Asia Pacific is an emerging segment in the oral proteins and peptides market and is expected to grow at a lucrative rate during the forecast period. China and India dominate the Asia Pacific oral proteins and peptides market. The market is strongly driven by a large patient pool, rising geriatric population, large-scale private and government investments in research and development activities followed by a rapidly developing biopharmaceutical industry. Rapidly increasing healthcare infrastructure is a major attributing factor for the growth of oral proteins and peptides market in Latin America and the Middle East & Africa.

Some of the key players in oral proteins and peptides market include Allergan Plc, Chiasma, Inc., Synthetic Biologics, Generex Biotechnology Corp., Proxima Concepts Limited (Diabetology Ltd.), Novo Nordisk A/S, and Tarsa Therapeutics Inc., Synergy Pharmaceuticals Inc., Sanofi S.A., Biocon Limited, F. Hoffmann-La Roche AG, AstraZeneca Plc, Inc., Hovione Limited, Novartis International AG, among others.

Browse the full "Oral Proteins and Peptides Market by Drug Type (Linaclotide, Plecanatide, Calcitonin, Insulin, and Octreotide) and by Application (Gastric & Digestive Disorders, Bone Diseases, Diabetes, Hormonal Disorders, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 – 2024" report at https://www.zionmarketresearch.com/report/oral-proteins-and-peptides-market

This report segments the global oral proteins and peptides market as follows:

Global Oral Proteins and Peptides Market: Drug Type Segment Analysis

  • Integrated Software
  • Linaclotide
  • Plecanatide
  • Calcitonin
  • Insulin 
  • Octreotide 

Global Oral Proteins and Peptides Market: Application Segment Analysis

  • Gastric & Digestive Disorders
  • Bone Diseases
  • Diabetes 
  • Hormonal Disorders
  • Others

Global Oral Proteins and Peptides Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

Related Reports:

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research
Follow Us Twitter: https://twitter.com/zion_research

Blog: http://www.intenseresearch.com | http://www.mrsresearchgroup.com | http://www.marketresearchtrade.com | https://qyresearchgroup.com | http://marketnreports.com | https://zmrnewsjournal.us | http://www.e-marketresearch.com

Contact Us:

Joel John
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com

Website: https://www.zionmarketresearch.com

Blog: http://zmrblog.com